Wednesday, April 19, 2023

NIAID Funding News, April 19, 2023

NIH/NIAID Template Banner

April 19, 2023 NIAID Funding News

Read this full edition online at https://www.niaid.nih.gov/grants-contracts/funding-news?edition=2023-04-19

Feature Articles 

Address Just-in-Time Requests and Bars to Award Quickly

While most of the just-in-time information we request is routine, be aware that certain codes and comments in your summary statement can indicate a funding restriction or bar to award.

Opportunities and Resources

Conduct epidemiological and observational research projects on the long-term cardiopulmonary sequelae following treatment for tuberculosis in persons living with and without HIV infection.

In your application, describe plans to develop either small animal models or surrogate virus-host systems for hepatitis B virus or hepatitis C virus research.

NIAID aims to spur new approaches that target HIV transcription to shut down the expression of HIV RNA, proteins, and virus that occurs despite interruption of the viral life cycle by antiretroviral therapy.

In The News

What are the gaps and barriers to developing, diversifying, and sustaining a diverse extramural scientific workforce and building a scientific pipeline to support the NIAID mission?

NIH will allow applicants to submit preliminary data as post-submission materials for new applications (Type 1) if the notice of funding opportunity uses the R01, R03, or R21 activity codes and allows preliminary data.

Be careful not to over-cite publications, such as preprints, as well as training- and resource-type awards. If an award's only contribution to a publication is non-personnel resources, do not list the paper.

FDA and HHS's Office for Human Research Protections published Draft Guidance to help stakeholders understand the processes used for review of research involving children as subjects that is not otherwise approvable by an institutional review board.

Advice Corner

Know how to respond if you get the error message "Data Management and Sharing Costs can only be entered on one of the lines in Section F Other Direct Costs within the same budget period."

Reader Questions

New Funding Opportunities

  • PAR-23-156, Lasker Clinical Research Scholars Program (Si2/R00, Clinical Trial Optional)
  • RFA-AI-23-023, International Research in Infectious Diseases (R01, Clinical Trial Not Allowed)
  • NOT-EB-23-002, Notice of Special Interest (NOSI)—Synthetic Biology for Biomedical Applications
  • PAR-23-171, Diagnostic Centers of Excellence (X01, Clinical Trial Not Allowed)
  • RFA-AI-23-028, Fundamental Research to Understand the Mechanisms of Neurotropic Virus-mediated Disease (R01, Clinical Trial Not Allowed)
  • RFP-DAIT-75N93023R00001, NIAID SPF Macaque Breeding Colonies

Find other announcements at NIAID Opportunities and Announcements.

Send suggestions or comments to deaweb@niaid.nih.gov.


This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107 GovDelivery logo

No comments:

Post a Comment

Most important medical advance in 100 years

Artificial Intelligence is being harnessed to create breakthrough drugs no one has ever seen before. ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ...